Sunday, August 23, 2009

“Women march for cancer awareness - BBC UK News” plus 4 more

Sponsored Links

“Women march for cancer awareness - BBC UK News” plus 4 more

Women march for cancer awareness - BBC UK News

Posted: 23 Aug 2009 08:25 AM PDT

Forty-six women have marched through central London wearing pink camouflage uniforms to encourage women to be screened for breast cancer.

The march was led by Lt Cdr Rachel Scandling, who had a double mastectomy after finding she carried a gene that increased her chances of cancer.

They marched from Tower Bridge to a Cancer Research UK laboratory at Lincoln's Inn Fields.

Parts of London have the lowest uptake of screening in the UK, the NHS found.

Its research showed that 47% of women in central and east London failed to attend screenings when invited.

The 46 marchers represented the 46,000 women diagnosed with breast cancer in the UK each year.

Lt Cdr Scandling said: "I have had to make some difficult choices in my fight for survival, but breast cancer is a battle that lots of women can win."



Print Sponsor



image

This posting includes an audio/video/photo media file: Download Now

The mum-daughter duo who beat cancer four times between them - New Kerala

Posted: 23 Aug 2009 09:01 AM PDT

London, Aug 23 : Mandy Kelly and six-year-old Eve are more than just the ordinary mother-daughter duo - they've beaten cancer four times between them.

Mandy and Eve have both struggled with cancer and have successfully fought it off each time.

The Mirror quoted Mandy as saying: 'We have beaten it together, and that really is a miracle...We have been there for each other and gave each other the strength to fight on.'

Eve took nine months of chemotherapy to come off the cancer, which started in her kidneys and spread to her lungs.

As Eve continued her fight with cancer, Mandy's breast cancer reappeared. The 47-year-old had already battled cancer twice but this time she need a needed a mastectomy (surgical removal of breasts completely or partially).

And this time the mother drew inspiration from her daughter's courage.

Mandy said: 'I knew if she could do it, I could do it too...Eve gave me the strength to beat it again. She knew I had already beaten cancer twice when she was diagnosed, so that encouraged her.

'She had seen me come through it, and so could she.'

Mandy, was first diagnosed with breast cancer in 1998 and it was cured after treatment.

But in autumn of 2003, Mandy developed a new lump in her breast. The cancer had reappeared.

She said: 'I couldn't believe it...this hit me harder than the first time I was diagnosed with cancer as I now had a baby less than a year old. Eve had been a miracle baby for Richard and me as I'd conceived against all the odds. To be told that my cancer had come back was devastating.

'And it was tough trying to cope with a 10-month baby and having treatment for cancer as well. But Richard and my family gave me lots of support so I could get through it.

'My sister would have Eve when I went to hospital for my radiotherapy, or she'd come to hospital with me and wait with her in the waiting room.'

Fortunately for Mandy, her cancer was tracked in its initial stage. The lump was removed and she was declared fit.

Everything was going well, when in October 2006, Eve fell ill. Her scan showed signs of a kidney tumour.

Mandy said: 'This time, our world really did fall apart. To be told my three-year-old girl had cancer as well was too much to bear. I asked whether I could have passed it on in the womb and doctors reassured me I hadn't. It was just terrible bad luck.'

Eve's cancer was fast spreading to her lungs, so doctors fixed her an aggressive chemo session that ended in July 2007.

Last June Mandy was diagnosed with cancer for the third time. Now she was required to undergo a mastectomy. And she drew courage from her daughter.

'We were there for each other,' Mandy said. 'When we felt low, we loved to sit on the sofa watching children's TV and having a cuddle. I knew I could beat it again. I had to do it for Eve, because she'd been so brave.

'And it was nothing compared to watching her go through treatment. That was the toughest thing of all.'

Mandy completed the Race For Life event for Cancer Research to celebrate her recovery. This was her ninth year of participation and even Eve joined in with her.

She said: 'Walking across the finish line with my little girl was an amazing feeling.... That mum-daughter thing is very special between us.

'In all, we've faced cancer four times - and we couldn't have done it without each other.'



image

This posting includes an audio/video/photo media file: Download Now

DS Waters of America, Inc. Partners With Susan G. Komen for the Cure - dBusinessNews.com

Posted: 23 Aug 2009 06:02 AM PDT

Atlanta - ATLANTA -- DS Waters of America, Inc., a leader in the home and office bottled water, filtration and office coffee delivery service today announced it has entered a three-year alliance with Susan G. Komen for the Cure , the world's largest breast cancer advocacy group. Through its home and office bottled water brands, DS Waters will make a $30.00 donation to Komen for the Cure for every new customer who starts service under the Komen Budget Plan, with a minimum annual donation of $100,000. The Komen Budget Plan program is supported by major direct mail, print and Internet campaigns throughout DS Waters' U.S. footprint.

"Our entire organization is excited to enter into a new alliance with Susan G. Komen for the Cure," said Joseph Silva, Director of Marketing for DS Waters. "We are honored to help raise funds and awareness for this dedicated organization determined to find the cures for breast cancer. Like so many others, this disease has impacted many of my close friends and family members and I am grateful to be a part of this unique opportunity. We are all extremely privileged to be associated with such a devoted team."

In addition to new customer incentives, DS Waters will roll out a referral program beginning in September and lasting through October calling on current customers to refer friends and family members to begin service. For each referral, DS Waters will make a donation to Komen for the Cure. In an effort to heighten awareness around the campaign, the caps on DS Waters' 5-gallon returnable bottles will change to pink in support of the initiative.

"Susan G. Komen for the Cure is excited to have DS Waters as a new partner in our promise to save lives and end breast cancer forever," said Katrina McGhee, VP of Global Partnerships at Komen for the Cure. "We rely heavily on our partners to help us create awareness for this disease and after visiting with DS Waters, we knew this was a great fit for our organization. We thank them for their generous commitment to the cause and spreading Komen's vision of a world without breast cancer to local communities."

"You may already be familiar with the bright green trucks within the majority of our fleet," said Dillon Schickli, Co-CEO for DS Waters, "but now you will see something more. We will display a new 'Proud Partner of Susan G. Komen for the Cure ' decal on all of our bottled water delivery service vehicles. This will serve as a reminder to our local communities of our commitment to the breast cancer movement. We hope to help make a difference in the fight for the cures one customer at a time."

DS Waters was inspired to partner with Komen for the Cure as a part of their dedication and ties to local communities, as well as their goal to provide responsible corporate citizenship. "Many of our employees families, friends and loved ones have been impacted by this disease and we are proud to be united with Susan G. Komen for the Cure, an incredible organization dedicated to saving lives and ending breast cancer forever," said Stewart Allen Co-CEO, DS Waters. "This new alliance is our way of extending support to the community by offering those who select our brands of home or office bottled water delivery service an opportunity to help join us in the fight against breast cancer."

About DS Waters of America, Inc.

Created in 2003, DS Waters is the producer and distributor of home, office, and retail bottled water products across the United States under the brand names Alhambra , Belmont Springs , Crystal Springs , Hinckley Springs , Kentwood Springs , Nursery Water, Sierra Springs and Sparkletts , and Roast2Coast , a coffee delivery service. The company, headquartered in Atlanta, Georgia, is the U.S. leader in home and office water delivery, focusing on five gallon, one gallon, and single serve bottled water products. Water is bottled at 26 manufacturing facilities and then delivered to millions of homes and offices, as well as retail establishments across the country. DS Waters employs approximately 4,500 Associates in 40 states. Visit www.water.com or www.NurseryWater.com for more information.

About Susan G. Komen for the Cure

Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure and launched the global breast cancer movement. Today, Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure, we have invested more than $1.3 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world. For more information about Susan G. Komen for the Cure, breast health or breast cancer, visit www.komen.org or call 1-877 GO KOMEN.



image

This posting includes an audio/video/photo media file: Download Now

KATU's Golf for the Cure raises $58,000 - Katu.com

Posted: 23 Aug 2009 12:07 PM PDT

ALOHA, Ore. – Golf for the Cure set a new fund-raising record for Susan G. Komen for the Cure in Oregon and Southwest Washington on Saturday.

The golf tournament and dinner auction, spearheaded by KATU Problem Solver and breast cancer survivor, Shellie Bailey-Shah, raised an estimated $58,000 toward breast cancer detection, education and services. That is the largest fund-raising effort by a non-Komen organization in this area.

"I am truly overwhelmed by the support in the Portland metro area, " said Shellie. "We exceeded my goal, and I have pretty high goals."

The amount raised is equivalent to the cost of 753 potentially life-saving mammograms, or 12 percent of what Komen is currently able to fund in Oregon and Southwest Washington.

The event, sponsored by KATU and the Northwestern University Alumni Club of Portland, drew 300 people to the Reserve Vineyards and Golf Club in Aloha, including golfers in the KATU family: Steve Dunn, Natali Marmion, Rhonda Shelby and Thom Jensen.

During the event, Shellie honored the OHSU team that she credits with saving her life. Her oncologist Dr. Shiuh-Wen Luoh, her surgeon Dr. Arpana Naik and several of her chemotherapy nurses were in attendance. They were recognized with a standing ovation from the crowd.

"Now let's work to put them out of business," laughed Shellie, as she continued the auction.

Twenty-five percent of the money raised from Golf for the Cure will go to breast cancer research. The remaining 75 percent will stay in the community to fund free mammograms for uninsured and underinsured women and transportation services to life-saving treatments.

You can still help! To donate to Golf for the Cure, click on this link: Donate to Golf for the Cure.

 

Additional information:

Shellie Bailey -Shah talks about her illness and recovery on AM Northwest, part I

Shellie Bailey -Shah talks about her illness and recovery on AM Northwest, part II

Breastfeeding reduces breast cancer risk in high-risk women

Breast cancer genes can come from father

Male relatives face risk from breast cancer genes

 

 



image

This posting includes an audio/video/photo media file: Download Now

Breast Cancer Trial Examines Shorter Radiation Course - Medical News Today

Posted: 22 Aug 2009 12:56 AM PDT


Main Category: Breast Cancer
Also Included In: Radiology / Nuclear Medicine; Clinical Trials / Drug Trials
Article Date: 22 Aug 2009 - 1:00 PDT

email icon email to a friend printer icon printer friendly write icon view / write opinions rate icon rate article



Researchers at The Cancer Institute of New Jersey (CINJ) have launched a clinical trial that focuses on a shorter course of radiation treatment for those with early-stage breast cancer. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

Studies have shown that giving radiation therapy to the breast after the cancer is removed through surgery (lumpectomy) helps keep the disease from coming back in that area. The current treatment standard is known as whole breast irradiation (WBI), in which radiation is targeted at the entire breast. It is given for five days a week for five to seven weeks. Partial breast irradiation (PBI) is also used, but is only targeted to the area of the breast where the lumpectomy was performed. This treatment is given twice a day for five days. Many patients, however, are not suitable candidates for PBI, and thus require WBI, which can be burdensome for many women due to the length of treatment.

In this study, women who are not suitable for PBI alone will receive a shorter course of WBI. The daily radiation dose to be delivered will be higher in the WBI treatment than in the standard course.

Atif Khan, MD, a radiation oncologist at CINJ and assistant professor of radiation oncology at UMDNJ-Robert Wood Johnson Medical School, is the lead investigator of the study. "By offering a more accelerated course of radiation over a shorter period of time, we hope we can provide another option to those patients who are not good candidates for PBI," he said. "And since we're cutting the treatment time by nearly half, that is less time patients will need to spend traveling to and from the treatment site, thus improving their quality of life."

Before taking part in the trial, interested participants will undergo a physical exam, mammogram, chest x-ray and other tests. Participants who are selected will have radiation treatment to the whole breast once a day for 11 days. They will also receive four treatments to the immediate area where the lumpectomy was performed either before or after the whole breast treatments. The entire treatment course will be complete in three weeks. Following treatment, participants will have follow-up physical exams and a mammogram at regular intervals for the next five years.

Women over age 18 who are diagnosed with early stage breast cancer and have had or are going to have a lumpectomy to remove the disease, are eligible to participate, although other criteria also must be met.

Clinical trials, often called cancer research studies, test new treatments and new ways of using existing treatments for cancer. At CINJ, researchers use these studies to answer questions about how a treatment affects the human body and to make sure it is safe and effective. There are several types of clinical trials currently underway at CINJ, including those that diagnose, treat, prevent, and manage symptoms of cancer. Many treatments used today, whether drugs or vaccines; ways to do surgery or give radiation therapy; or combinations of treatments, are the results of past clinical trials.

As New Jersey's only National Cancer Institute-designated Comprehensive Cancer Center, CINJ offers patients access to treatment options not available at other institutions within the state. CINJ currently enrolls more than 1,000 patients on clinical trials, including approximately 15 percent of all new adult cancer patients and approximately 70 percent of all pediatric cancer patients. Enrollment in these studies nationwide is fewer than five percent of all adult cancer patients.

About The Cancer Institute of New Jersey

The Cancer Institute of New Jersey is the state's first and only National Cancer Institute-designated Comprehensive Cancer Center, and is dedicated to improving the prevention, detection, treatment and care of patients with cancer. CINJ's physician-scientists engage in translational research, transforming their laboratory discoveries into clinical practice, quite literally bringing research to life.

The Cancer Institute of New Jersey Network is comprised of hospitals throughout the state and provides a mechanism to rapidly disseminate important discoveries into the community. Flagship Hospital: Robert Wood Johnson University Hospital. Major Clinical Research Affiliate Hospitals: Carol G. Simon Cancer Center at Morristown Memorial Hospital, Carol G. Simon Cancer Center at Overlook Hospital, and Jersey Shore University Medical Center. Affiliate Hospitals: Bayshore Community Hospital, CentraState Healthcare System, Cooper University Hospital*, JFK Medical Center, Mountainside Hospital, Raritan Bay Medical Center, Robert Wood Johnson University Hospital at Hamilton (CINJ at Hamilton), Saint Peter's University Hospital, Somerset Medical Center, Southern Ocean County Hospital, The University Hospital/UMDNJ-New Jersey Medical School*, and University Medical Center at Princeton.

Source: Cancer Institute of New Jersey



image

This posting includes an audio/video/photo media file: Download Now

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)